[Serial determination of carcinoembryonic antigen in the follow-up of patients with malignant tumours (author's transl)].
Carcinoembryonic antigen (CEA) was determined serially in 54 patients with malignant tumour (other than colorectal ones). Patients in remission (21), those resistant to treatment (16) and a group not receiving treatment (17) showed a good correlation between growth behaviour of the tumour and titre changes. Best correlation was in 21 patients who after treatment with cytostatic agents, hormones or radiation had objective signs of remission. Serial determination of CEA is thus of value in the control of treatment of malignant tumours other than those of the colorectum.
D000328:Adult; D002272:Carcinoembryonic Antigen / Q000032:analysis*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D009369:Neoplasms / Q000276:immunology* / Q000628:therapy
D002272:Carcinoembryonic Antigen
Carcinoembryonales Antigen zur Verlaufskontrolle maligner Tumoren. Diagnostischer Wert der serienmässigen Bestimmung.